Baricitinib Drug
- All
- News
-
WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus.
-
Bajaj Healthcare Hits Record High On Applying For Covid-19 Drug Patent
Shares of Bajaj Healthcare rallied as much as 20% to hit record high of Rs 863.95 after it moved India Patent Office requesting to grant a compulsory license for manufacturing and supply of Covid-19 drug Baricitinib.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus.
-
Bajaj Healthcare Hits Record High On Applying For Covid-19 Drug Patent
Shares of Bajaj Healthcare rallied as much as 20% to hit record high of Rs 863.95 after it moved India Patent Office requesting to grant a compulsory license for manufacturing and supply of Covid-19 drug Baricitinib.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
